List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 183 studies with search of: "Rosiglitazone"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Rosiglitazone (BRL49653C)
2 Recruiting Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Recombinant Human Growth Hormone;   Drug: Rosiglitazone;   Drug: Recombinant Human Growth Hormone and Rosiglitazone;   Drug: Placebo human growth hormone and placebo rosiglitazone
3 Recruiting Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: avandia plus metformin;   Drug: avandia plus losartan
4 Completed Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone
Condition: Healthy
Interventions: Drug: Rosiglitazone alone;   Drug: Rosiglitazone plus quinine sulfate
5 Recruiting Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
Conditions: Type 4 Hyperlipidemia;   Normoglycemia
Interventions: Drug: Rosiglitazone;   Drug: Placebo (Rosiglitazone);   Drug: Placebo (Fenofibrate);   Drug: Fenofibrate
6 Active, not recruiting Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Prostate Cancer
Interventions: Drug: Rosiglitazone;   Other: Placebo
7 Completed A Study Of BRL49653C For The Treatment Of Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: rosiglitazone
8 Completed Rosiglitazone Versus Theophylline in Asthmatic Smokers
Condition: Asthma
Interventions: Drug: rosiglitazone;   Drug: theophylline;   Drug: beclomethasone;   Drug: inhaled beclomethasone and oral theophylline
9 Completed BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: Rosiglitazone
10 Completed Fluid Retention in AVANDIA Treated Subjects With Autonomic Neuropathy
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: AVANDIA (rosiglitazone)
11 Completed Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
Condition: HIV Infections
Interventions: Drug: Rosiglitazone maleate;   Drug: Atazanavir Sulphate;   Drug: Atazanavir Sulphate + Rosiglitazone maleate;   Drug: Atazanavir Sulphate + Ritonavir;   Drug: Atazanavir Sulphate + Ritonavir + Rosiglitazone maleate
12 Completed An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: exenatide;   Drug: rosiglitazone
13 Completed Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
Conditions: Diabetes;   Coronary Artery Bypass Grafting
Intervention: Drug: Rosiglitazone or placebo
14 Completed Rosiglitazone on Microalbuminuria in Type 2 Diabetics
Conditions: Type 2 Diabetes Mellitus;   Microalbuminuria
Intervention: Drug: Rosiglitazone
15 Completed A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Rosiglitazone 4 mg
16 Completed Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: rosiglitazone
17 Completed Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: rosiglitazone maleate/metformin hydrochloride
18 Active, not recruiting Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: rosiglitazone maleate
19 Terminated Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Condition: Mild-to-Moderate Alzheimer
Intervention: Drug: Rosiglitazone XR
20 Terminated Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Condition: Mild-to-Moderate Alzheimers Disease
Intervention: Drug: Rosiglitazone XR

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services